Class information for:
Level 1: SMALLPOX//ORTHOPOXVIRUS//SMALLPOX VACCINE

Basic class information

Class id #P Avg. number of
references
Database coverage
of references
4078 1851 33.5 62%



Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes

The table includes all classes above and classes immediately below the current class.



Cluster id Level Cluster label #P
7 4 INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY 1353914
713 3       POXVIRUS//VACCINIA VIRUS//ORTHOPOXVIRUS 5641
1969 2             POXVIRUS//VACCINIA VIRUS//ORTHOPOXVIRUS 5641
4078 1                   SMALLPOX//ORTHOPOXVIRUS//SMALLPOX VACCINE 1851

Terms with highest relevance score



rank Term termType Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 SMALLPOX authKW 1563213 10% 49% 193
2 ORTHOPOXVIRUS authKW 1444703 7% 65% 134
3 SMALLPOX VACCINE authKW 841891 4% 73% 70
4 MONKEYPOX authKW 623001 3% 79% 48
5 COWPOX VIRUS authKW 534393 3% 60% 54
6 COWPOX authKW 425207 2% 66% 39
7 VACCINIA authKW 405415 5% 29% 84
8 VACCINIA VIRUS authKW 392938 7% 18% 131
9 VARIOLA authKW 362068 2% 73% 30
10 POXVIRUS RABIES BRANCH address 330323 3% 39% 52

Web of Science journal categories



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 Virology 19238 25% 0% 457
2 Infectious Diseases 5440 17% 0% 308
3 Immunology 5276 27% 0% 491
4 Microbiology 2120 15% 0% 282
5 Veterinary Sciences 2001 12% 0% 231
6 Medicine, Research & Experimental 776 9% 0% 161
7 Public, Environmental & Occupational Health 629 9% 0% 163
8 Tropical Medicine 334 2% 0% 41
9 Dermatology 228 3% 0% 59
10 Medicine, General & Internal 171 6% 0% 114

Address terms



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 POXVIRUS RABIES BRANCH 330323 3% 39% 52
2 POXVIRUS PROGRAM 190172 1% 82% 14
3 SMALLPOX ERADICAT PROGRAM 117296 0% 89% 8
4 MIL VACCINE AGCY 99784 1% 55% 11
5 PROGRAM VIRAL PATHOGENESIS 98970 0% 100% 6
6 BIODEF CLIN BRANCH 62090 0% 47% 8
7 VACCINE HEALTHCARE NETWORK 57725 0% 50% 7
8 EMERGING VIRAL PATHOGENS SECT 47505 1% 26% 11
9 CIDV BIODESIGN 43984 0% 67% 4
10 PESQUISA VIROL ANIM 40592 0% 31% 8

Journals



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 VACCINE 11959 6% 1% 115
2 EMERGING INFECTIOUS DISEASES 9622 3% 1% 58
3 ANTIVIRAL RESEARCH 7945 2% 1% 41
4 BIOSECURITY AND BIOTERRORISM-BIODEFENSE STRATEGY PRACTICE AND SCIENCE 6216 1% 3% 11
5 LABORATORY ANIMAL SCIENCE 5642 2% 1% 28
6 WHO CHRONICLE 4116 0% 6% 4
7 CLINICAL INFECTIOUS DISEASES 3951 3% 0% 56
8 JOURNAL OF VIROLOGY 3548 5% 0% 94
9 VIRUSES-BASEL 2884 1% 1% 17
10 JOURNAL OF CAMEL PRACTICE AND RESEARCH 2601 1% 1% 12

Author Key Words



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
LCSH search Wikipedia search
1 SMALLPOX 1563213 10% 49% 193 Search SMALLPOX Search SMALLPOX
2 ORTHOPOXVIRUS 1444703 7% 65% 134 Search ORTHOPOXVIRUS Search ORTHOPOXVIRUS
3 SMALLPOX VACCINE 841891 4% 73% 70 Search SMALLPOX+VACCINE Search SMALLPOX+VACCINE
4 MONKEYPOX 623001 3% 79% 48 Search MONKEYPOX Search MONKEYPOX
5 COWPOX VIRUS 534393 3% 60% 54 Search COWPOX+VIRUS Search COWPOX+VIRUS
6 COWPOX 425207 2% 66% 39 Search COWPOX Search COWPOX
7 VACCINIA 405415 5% 29% 84 Search VACCINIA Search VACCINIA
8 VACCINIA VIRUS 392938 7% 18% 131 Search VACCINIA+VIRUS Search VACCINIA+VIRUS
9 VARIOLA 362068 2% 73% 30 Search VARIOLA Search VARIOLA
10 CAMELPOX 297732 1% 95% 19 Search CAMELPOX Search CAMELPOX

Core articles

The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.



Rank Reference # ref. in
cl.
Shr. of ref. in
cl.
Citations
1 MOSS, B , (2011) SMALLPOX VACCINES: TARGETS OF PROTECTIVE IMMUNITY.IMMUNOLOGICAL REVIEWS. VOL. 239. ISSUE . P. 8-26 141 57% 56
2 MESEDA, CA , WEIR, JP , (2010) THIRD-GENERATION SMALLPOX VACCINES: CHALLENGES IN THE ABSENCE OF CLINICAL SMALLPOX.FUTURE MICROBIOLOGY. VOL. 5. ISSUE 9. P. 1367 -1382 100 84% 2
3 VOIGT, EA , KENNEDY, RB , POLAND, GA , (2016) DEFENDING AGAINST SMALLPOX: A FOCUS ON VACCINES.EXPERT REVIEW OF VACCINES. VOL. 15. ISSUE 9. P. 1197 -1211 96 74% 0
4 PARKER, S , BULLER, RM , (2013) A REVIEW OF EXPERIMENTAL AND NATURAL INFECTIONS OF ANIMALS WITH MONKEYPOX VIRUS BETWEEN 1958 AND 2012.FUTURE VIROLOGY. VOL. 8. ISSUE 2. P. 129 -157 61 90% 9
5 PARKER, S , CRUMP, R , FOSTER, S , HARTZLER, H , HEMBRADOR, E , LANIER, ER , PAINTER, G , SCHRIEWER, J , TROST, LC , BULLER, RM , (2014) CO-ADMINISTRATION OF THE BROAD-SPECTRUM ANTIVIRAL, BRINCIDOFOVIR (CMX001), WITH SMALLPOX VACCINE DOES NOT COMPROMISE VACCINE PROTECTION IN MICE CHALLENGED WITH ECTROMELIA VIRUS.ANTIVIRAL RESEARCH. VOL. 111. ISSUE . P. 42 -52 57 92% 2
6 ABRAHAO, JS , DA FONSECA, FG , TRINDADE, GD , KROON, EG , MOTA, BEF , (2011) ZOONOTIC BRAZILIAN VACCINIA VIRUS: FROM FIELD TO THERAPY.ANTIVIRAL RESEARCH. VOL. 92. ISSUE 2. P. 150 -163 78 68% 12
7 KECKLER, MS , CARROLL, DS , GALLARDO-ROMERO, NF , LASH, RR , SALZER, JS , WEISS, SL , PATEL, N , CLEMMONS, CJ , SMITH, SK , HUTSON, CL , ET AL (2011) ESTABLISHMENT OF THE BLACK-TAILED PRAIRIE DOG (CYNOMYS LUDOVICIANUS) AS A NOVEL ANIMAL MODEL FOR COMPARING SMALLPOX VACCINES ADMINISTERED PREEXPOSURE IN BOTH HIGH- AND LOW-DOSE MONKEYPOX VIRUS CHALLENGES.JOURNAL OF VIROLOGY. VOL. 85. ISSUE 15. P. 7683 -7698 58 88% 13
8 KENNEDY, RB , OVSYANNIKOVA, I , POLAND, GA , (2009) SMALLPOX VACCINES FOR BIODEFENSE.VACCINE. VOL. 27. ISSUE . P. D73-D79 71 75% 17
9 REYNOLDS, MG , DAMON, IK , (2012) OUTBREAKS OF HUMAN MONKEYPOX AFTER CESSATION OF SMALLPOX VACCINATION.TRENDS IN MICROBIOLOGY. VOL. 20. ISSUE 2. P. 80-87 56 82% 22
10 PARAN, N , SUTTER, G , (2009) SMALLPOX VACCINES NEW FORMULATIONS AND REVISED STRATEGIES FOR VACCINATION.HUMAN VACCINES. VOL. 5. ISSUE 12. P. 824 -831 72 73% 9

Classes with closest relation at Level 1



Rank Class id link
1 1255 POXVIRUS//VACCINIA VIRUS//MYXOMA VIRUS
2 15897 ORF VIRUS//PARAPOXVIRUS//CONTAGIOUS ECTHYMA
3 10470 ACYCLIC NUCLEOSIDE PHOSPHONATES//PMEA//CIDOFOVIR
4 23404 CAPRIPOXVIRUS//LUMPY SKIN DISEASE//SHEEP POX
5 22249 PROGRAM TRANSLAT IMMUNOVIROL BIODEF//MAYO VACCINE GRP//VACCINE GRP
6 25957 FRANCISCO XAVIER BALMIS//SMALLPOX INOCULATION//GLOBAL HLTH HIST
7 21189 MOLLUSCUM CONTAGIOSUM//MOLLUSCUM CONTAGIOSUM VIRUS//MOLLUSCA CONTAGIOSA
8 29682 MASS DISPENSING//POINT OF DISPENSING//DENNIS AVE HLTH
9 12424 HIV VACCINE//MOL MUCOSAL VACCINE IMMUNOL GRP//HIV VACCINE TRIALS NETWORK
10 35908 ISTHMIN//METEORIN//AUTOIMMUNE HOST

Go to start page